Nishant C. Saxena - 11 Aug 2026 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Reporting relationship: Chief Business Officer
Issuer ticker: CRBP
Reported as of: 11 Aug 2026
Net transaction value: +$25,036
SEC form: 4
Accepted by SEC: 12 Aug 2026, 16:30:08 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/Meghan Houghton, Attorney-in-Fact for Nishant Saxena

Key filing fact

Nishant C. Saxena filed Form 4 for Corbus Pharmaceuticals Holdings, Inc. (CRBP) on 12 Aug 2026.

Key facts

This page summarizes Nishant C. Saxena's Form 4 filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Aug 2026, 16:30.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0002136365 Primary reporting owner

Relationship: Chief Business Officer
Address: C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 500 RIVER RIDGE DRIVE, NORWOOD
Signature: /s/Meghan Houghton, Attorney-in-Fact for Nishant Saxena
Signature date: 12 Aug 2026

Shares, units, or other non-derivative securities reported in this filing.

CRBP transaction

Purchase

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported.